Undertreatment of coronary heart disease in patients undergoing coronary artery bypass surgery.
作者信息
Sambu N, Wald D S, Seddon M, Simpson I A
出版信息
Heart. 2006 May;92(5):697-8. doi: 10.1136/hrt.2005.069914.
Abstract
摘要
相似文献
1
Undertreatment of coronary heart disease in patients undergoing coronary artery bypass surgery.
Heart. 2006 May;92(5):697-8. doi: 10.1136/hrt.2005.069914.
2
The clinical spectrum of coronary artery disease and its surgical and medical management, 1974-1979. The Coronary Artery Surgery study.
Circulation. 1982 Nov;66(5 Pt 2):III16-23.
3
Patterns and predictors of statin use after coronary artery bypass graft surgery.
J Thorac Cardiovasc Surg. 2007 Oct;134(4):932-8. doi: 10.1016/j.jtcvs.2007.05.039.
4
Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
J Lab Clin Med. 1985 Mar;105(3):397-402.
5
[Administration of verapamil and propranolol for 4 years in a patient with aortocoronary bypass].
Srp Arh Celok Lek. 1985 Mar;113(3):269-75.
6
Estimated contribution of coronary artery bypass graft surgery to the decline in coronary heart disease mortality: the Minnesota Heart Survey.
J Am Coll Cardiol. 1994 Jul;24(1):95-103. doi: 10.1016/0735-1097(94)90547-9.
7
Life expectancy after coronary artery bypass surgery.
Thorac Cardiovasc Surg. 1981 Aug;29(4):212-5. doi: 10.1055/s-2007-1023479.
8
Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.
J Thorac Cardiovasc Surg. 2007 Jul;134(1):132-8. doi: 10.1016/j.jtcvs.2007.01.055.
9
Effect of coronary artery bypass graft surgery on survival.
Lancet. 1994 Oct 29;344(8931):1223; author reply 1224.
10
Comparison of coronary artery bypass surgery and medical therapy in patients with exercised-induced silent myocardial ischemia: a report from the Coronary Artery Surgery Study (CASS) registry.
J Am Coll Cardiol. 1988 Sep;12(3):595-9. doi: 10.1016/s0735-1097(88)80043-3.
本文引用的文献
1
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.
Eur Heart J. 2003 Sep;24(17):1601-10. doi: 10.1016/s0195-668x(03)00347-6.
2
A strategy to reduce cardiovascular disease by more than 80%.
BMJ. 2003 Jun 28;326(7404):1419. doi: 10.1136/bmj.326.7404.1419.
3
Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey.
Heart. 2002 Aug;88(2):159-62. doi: 10.1136/heart.88.2.159.
4
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
Eur Heart J. 2001 Apr;22(7):554-72. doi: 10.1053/euhj.2001.2610.
Zotero 插件